Kayne Anderson BDC, Inc. Common Stock KBDC 深 滬
等待開盤 12-26 09:30:00 美东时间
14.76
+0.150
+1.03%
華盛通- 最 高14.78
- 今 開14.64
- 成交量 9.10万股
- 最 低 14.6201
- 昨 收 14.61
- 總市值 10.47亿
- 52周最高 16.59
- 市盈率 靜 7.13
- 換手率 0.13%
- 52周最低 13.03
- 委 比 -9.09%
- 總股本 7091.21万
- 歷史最高 16.59
- 量 比 0.13
- 振 幅 1.09%
- 歷史最低 13.06
- 每 手 1
- 風險率 0.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 高盛上调百度、美敦力、晶科能源等多只个股目标价；家得宝遭9家机构下调目标价；
今日重点评级关注：富国银行：维持Annexon"超配"评级，目标价从14美元升至27美元；瑞穗：上调Relmada Therapeutics评级至"跑赢大市"，目标价从1美元升至10美元
11-20 10:28
RBC Capital Maintains Outperform on Kayne Anderson BDC, Lowers Price Target to $16
RBC Capital analyst Kenneth S. Lee maintains Kayne Anderson BDC (NYSE:KBDC) with a Outperform and lowers the price target from $17 to $16.
11-20 00:00
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
11-13 09:58
Wells Fargo Maintains Overweight on Kayne Anderson BDC, Lowers Price Target to $15
Wells Fargo analyst Finian O'Shea maintains Kayne Anderson BDC (NYSE:KBDC) with a Overweight and lowers the price target from $16 to $15.
11-12 23:13
Kayne Anderson BDC Promotes Frank Karl To President
Kayne Anderson BDC, Inc. (NYSE:KBDC) ("KBDC" or the "Company"), a business development company externally managed by its investment adviser, KA Credit Advisors, LLC, an affiliate of Kayne Anderson Capital Advisors, LP
11-11 05:31
Kayne Anderson BDC Q3 EPS $0.43 Beats $0.40 Estimate, Sales $61.373M Beat $59.018M Estimate
Kayne Anderson BDC (NYSE:KBDC) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.40 by 8.86 percent. This is a 17.31 percent decrease over earnings of $0.52 per share from the
11-11 05:21
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
美股大行评级 | 麦格理首予哔哩哔哩"跑赢大市"评级，目标价36.03美元； 高盛首予联合健康集团"买入"评级，目标价406美元
今日重点评级关注：摩根士丹利：上调Alvotech评级至"超配"，目标价14美元；蒙特利尔银行：维持PG&E"跑赢大市"评级，目标价从23美元升至25美元
10-15 18:20
UBS Maintains Neutral on Kayne Anderson BDC, Lowers Price Target to $15
UBS analyst Doug Harter maintains Kayne Anderson BDC (NYSE:KBDC) with a Neutral and lowers the price target from $16.5 to $15.
10-15 00:32
